RETRACTED: MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 (vol 589, pg 102, 2015) (Retracted article. See vol. 596, pg. 526, 2022)

被引:38
作者
Kan, Heping [1 ]
Guo, Wenbin [2 ]
Huang, Yuqi [1 ]
Liu, Dingli [3 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Hepatobiliary Surg, Guangzhou 510515, Guangdong, Peoples R China
[2] Southern Med Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510000, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China
关键词
MicroRNA-520g; Hepatocellular carcinoma; Epithelial-mesenchymal transition; SMAD family member 7; Cancer metastasis; TGF-BETA; IDENTIFICATION; CONTRIBUTES; ANTAGONIST; SIGNATURES; INVASION; RECEPTOR; CANCER; MIRNAS;
D O I
10.1016/j.febslet.2014.11.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Aberrant expression of miRNAs contributes to HCC development. Here, we observed elevated miR-520g expression in tumor samples from HCC patients with relapse and metastasis, and this high miR-520g expression was correlated with poor survival. Through gain-and loss-of-function studies, miR-520g was demonstrated to facilitate HCC cell migration, invasion and epithelial-mesenchymal transition (EMT). SMAD7 was identified as a direct target of miR-520g. Accordingly, we conclude that high miR-520g expression promotes HCC cell mobility and EMT by targeting SMAD7, and this is correlated with reduced survival in HCC patients. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 109
页数:8
相关论文
共 25 条
[1]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[2]   miRNAs, cancer, and stem cell division [J].
Croce, CM ;
Calin, GA .
CELL, 2005, 122 (01) :6-7
[3]   Oncogenic extracellular vesicles in brain tumor progression [J].
D'Asti, Esterina ;
Garnier, Delphine ;
Lee, Tae H. ;
Montermini, Laura ;
Meehan, Brian ;
Rak, Janusz .
FRONTIERS IN PHYSIOLOGY, 2012, 3
[4]   Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications [J].
Friedman, Scott L. .
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2004, 1 (02) :98-105
[5]  
Garzon R, 2009, ANNU REV MED, V60, P167, DOI [10.1146/annurev.med.59.053006.104707, 10.1146/annurev.pathol.4.110807.092222]
[6]   MicroRNAs in vertebrate development [J].
Harfe, BD .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (04) :410-415
[7]   The MAD-related protein Smad7 associates with the TGF beta receptor and functions as an antagonist of TGF beta signaling [J].
Hayashi, H ;
Abdollah, S ;
Qiu, YB ;
Cai, JX ;
Xu, YY ;
Grinnell, BW ;
Richardson, MA ;
Topper, JN ;
Gimbrone, MA ;
Wrana, JL ;
Falb, D .
CELL, 1997, 89 (07) :1165-1173
[8]   TPX2 Is a Prognostic Marker and Contributes to Growth and Metastasis of Human Hepatocellular Carcinoma [J].
Huang, Yuqi ;
Guo, Wenbin ;
Kan, Heping .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (10) :18148-18161
[9]   MicroRNA and cancer [J].
Jansson, Martin D. ;
Lund, Anders H. .
MOLECULAR ONCOLOGY, 2012, 6 (06) :590-610
[10]   MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways [J].
Keklikoglou, I. ;
Koerner, C. ;
Schmidt, C. ;
Zhang, J. D. ;
Heckmann, D. ;
Shavinskaya, A. ;
Allgayer, H. ;
Gueckel, B. ;
Fehm, T. ;
Schneeweiss, A. ;
Sahin, Oe ;
Wiemann, S. ;
Tschulena, U. .
ONCOGENE, 2012, 31 (37) :4150-4163